COVID-19 Presents Difficulties for Adults with ADHD
Adults with ADHD may face a number of challenges during the ongoing pandemic.
Related Articles
2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD
Balmes discusses the latest annual State of the Air Report, which shows that 131 million Americans are living in areas with failing air quality grades.
Sharon K. Inouye, MD, MPH: Why is Delirium During Hospitalization Not Taken Seriously?
This ACP Conference interview featured a discussion with Inouye about gaps in knowledge regarding patients experiencing delirium during hospitalization.
Guselkumab, Risankizumab Boast Longest Drug Survival Among IL-17, IL-23 Inhibitors
A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.
Risankizumab Significantly Improves Skin, Joint Symptoms in PsA
Post-treatment with risankizumab, the cDAPSA score, PGA score, and PASI score substantially decreased among a cohort of patients with psoriatic arthritis.
Managing General Medical Inpatients with Psychiatric Illness, with Sejal Shah, MD
Shah discusses the prevalence of psychiatric illness among hospitalized patients and highlights key considerations for their management from her session at ACP.
Middle Age and Older Adults Perceive “Old Age” Begins Later Than a Decade Ago
A new study found the perceived onset of old age rose nearly 3 years from 1911 to 1953.
Patrick Hemming, MD: Which Mental Health App is Best for Internal Medicine Patients?
This segment of Hemming’s ACP interview featured a discussion of a website used to assess digital applications for patients struggling with mental health issues.
Plant-Based Diet Intervention Improves Disease Activity, Symptoms in RA, Osteoarthritis
Participants described the intervention as complete and coherent and would recommend this intervention to other patients.
A Rising Tide: The Impact of Climate Change on Allergic Disease
Cerceo, Peden, and Ziska joined HCPLive to speak on the imminent threat posed by climate change, highlighting the impact especially on individuals with allergic disease.
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts discuss the STEP HFpEF DM trial and the need for fair allocation of incretin-based therapies with ongoing shortages and overwhelming demand.